Imaging Biometrics Ltd. (LON:IBAI)
London · Delayed Price · Currency is GBP · Price in GBX 0.6300
-0.0700 (-10.00%)
Aug 12, 2026, 9:35 AM GMT
Imaging Biometrics Income Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.81 | 0.79 | 0.75 | 0.61 | 0.54 | 0.52 | |
Revenue Growth | 2.83% | 5.07% | 23.09% | 13.72% | 2.84% | 104.09% |
Cost of Revenue | 0.05 | 0.05 | 0.01 | 0.01 | 0 | 0.02 |
Gross Profit | 0.76 | 0.74 | 0.74 | 0.6 | 0.53 | 0.5 |
Selling, General & Admin | 0.74 | 0.89 | 1.07 | 1 | 0.9 | 0.86 |
Amortization of Goodwill & Intangibles | - | - | - | - | 0.14 | 0.13 |
Other Operating Expenses | -0 | -0 | -0 | -0 | -0 | -0 |
Operating Expenses | 0.74 | 0.89 | 1.07 | 1 | 1.03 | 0.99 |
Operating Income | 0.02 | -0.16 | -0.33 | -0.41 | -0.5 | -0.49 |
Interest Expense | -0.01 | -0 | - | -0.01 | -0.01 | -0.01 |
Other Non Operating Income (Expenses) | - | - | 0 | - | - | - |
EBT Excluding Unusual Items | 0.01 | -0.16 | -0.33 | -0.42 | -0.51 | -0.5 |
Impairment of Goodwill | - | - | - | -0.08 | - | - |
Asset Writedown | -0.24 | -0.24 | - | -0.13 | - | - |
Pretax Income | -0.23 | -0.4 | -0.33 | -0.62 | -0.51 | -0.5 |
Earnings From Continuing Operations | -0.24 | -0.4 | -0.33 | -0.62 | -0.51 | -0.5 |
Net Income | -0.24 | -0.4 | -0.33 | -0.62 | -0.51 | -0.5 |
Net Income to Common | -0.24 | -0.4 | -0.33 | -0.62 | -0.51 | -0.5 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 247 | 242 | 218 | 184 | 183 | 173 |
Shares Outstanding (Diluted) | 247 | 242 | 218 | 184 | 183 | 173 |
Shares Change | 2.17% | 10.80% | 18.65% | 0.60% | 5.70% | 16.72% |
EPS (Basic) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
EPS (Diluted) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | 0.15 | 0.07 | -0.14 | -0.1 | -0.38 | -0.29 |
Free Cash Flow Per Share | 0.00 | - | -0.00 | -0.00 | -0.00 | -0.00 |
Gross Margin | 94.01% | 93.55% | 98.97% | 98.09% | 99.67% | 96.73% |
Operating Margin | 2.62% | -19.93% | -43.66% | -66.68% | -93.47% | -94.10% |
Profit Margin | -29.30% | -50.87% | -43.61% | -102.37% | -95.47% | -96.16% |
Free Cash Flow Margin | 18.96% | 9.43% | -18.15% | -15.89% | -70.20% | -56.54% |
EBITDA | 0.12 | -0.07 | -0.27 | -0.29 | -0.36 | -0.36 |
EBITDA Margin | 15.04% | -8.37% | -36.40% | -47.74% | -67.23% | -68.49% |
D&A For EBITDA | 0.1 | 0.09 | 0.05 | 0.12 | 0.14 | 0.13 |
EBIT | 0.02 | -0.16 | -0.33 | -0.41 | -0.5 | -0.49 |
EBIT Margin | 2.62% | -19.93% | -43.66% | -66.68% | -93.47% | -94.10% |